Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 5Brain Neoplasms 4Lymphoma 3Leukemia 3Glioblastoma 3Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Lymphocytic, Chronic, B-Cell 2Glioma 2Astrocytoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Refractory Solid Tumors 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neurologic Manifestations 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms 1Mouth Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1

Interventions

Nivolumab 13Surveys and Questionnaires 6Ipilimumab 6linrodostat 5Standard of Care 5Paclitaxel 5Bevacizumab 5Sirolimus 4Pemetrexed 4Interviews as Topic 4Gemcitabine 4Docetaxel 4ARRY-334543 4temsirolimus 3relatlimab 3Erlotinib Hydrochloride 3Cetuximab 3Carboplatin 3regorafenib 2anlotinib 2abemaciclib 2Vorinostat 2Trastuzumab 2Sorafenib 2N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Dasatinib 2Cyclophosphamide 2vorolanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Cancer × Valproic Acid × Clear all
NCT00530907 2015-01-08

Valproic Acid and Bevacizumab in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
71 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡